Study to Evaluate Efficacy and Safety of NDS-446 in Men With Lower Urinary Tract Symptoms (LUTS)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Prospective, Randomized, Double-Blind, Placebo Controlled clinical trial to study the
efficacy and the safety of NDS-446 (500 mg/cap) in Men 45 years of age or older with moderate
to severe lower urinary tract symptoms (LUTS)